Position
FIRST MANHATTAN CO. LLC. in DiaMedica Therapeutics Inc.
Back to the book · All holders of DMAC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$482K$7.96 → $6.77
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 405K | $3.22M | — | — | — | 0.0% |
| Q1 2026 | 455K | $3.08M | $6.77 | −$482K | $338.5K | 0.0% |